Case Reports in Infectious Diseases

Case Reports in Infectious Diseases / 2012 / Article

Case Report | Open Access

Volume 2012 |Article ID 508503 | 3 pages | https://doi.org/10.1155/2012/508503

Purpura Fulminans Secondary to Streptococcus pneumoniae Meningitis

Academic Editor: M. du Plessis
Received03 Oct 2011
Accepted23 Oct 2011
Published26 Jan 2012

Abstract

Purpura fulminans (PF) is a rare skin disorder with extensive areas of blueblack hemorrhagic necrosis. Patients manifest typical laboratory signs of disseminated intravascular coagulation (DIC). Our case describes a 37-year-old previously healthy man who presented with 3 days of generalized malaise, headache, vomiting, photophobia, and an ecchymotic skin rash. Initial laboratory workup revealed DIC without obvious infectious trigger including unremarkable cerebrospinal fluid (CSF) biochemical analysis. There was further progression of the skin ecchymosis and multiorgan damage consistent with PF. Final CSF cultures revealed Streptococcus pneumoniae. Despite normal initial CSF biochemical analysis, bacterial meningitis should always be considered in patients with otherwise unexplained DIC as this may be an early manifestation of infection. PF is a clinical diagnosis that requires early recognition and prompt empirical treatment, especially, in patients with progressive altered mental status, ecchymotic skin rash, and DIC.

1. Introduction

Purpura fulminans (PF) is an unusual skin manifestation of disseminated intravascular coagulation (DIC) associated with infection and/or sepsis. It is characterized by tissue necrosis, small vessel thrombosis in the setting of DIC. PF often leads to end organ damage with resultant profound morbidity and mortality. We describe a case of PF secondary to Streptococcus pneumoniae infection.

2. Case Presentation

A 37-year-old previously healthy man presented to the emergency department with 3 days of generalized malaise, headache, nausea, vomiting, photophobia, and an ecchymotic skin rash. Admission physical evaluation revealed that he was tachycardic, somnolent, but oriented without nuchal rigidity or focal neurologic signs. He had a diffuse ecchymotic nonblanching macular rash on his extremities and abdomen (Figures 1, 2, and 3).

Initial laboratory tests revealed leukocytosis (25 × 109/L), thrombocytopenia (32 × 109/L), and normal hemoglobin. Coagulation studies showed prothrombin time of 15.6 seconds, partial thromboplastin time of 37 seconds, fibrinogen 10.9 μmol/L, and D-dimer >20000 μg/L consistent with DIC. Liver and renal function tests revealed AST 117 U/L, ALT 65 U/L, total bilirubin 20.2 μmol/L, BUN 20.3 mmol/L, and creatinine 247.52 μmol/L. Initial cerebrospinal fluid (CSF) analysis was within normal limits (WBC 1 × 106/L, RBC 1 × 106/L, glucose 2.9 mmol/L, protein 0.47 g/L, and no organisms seen on gram stain). Serology for HIV, EBV, CMV, and hepatitis viruses was negative, as well as serologic testing for rickettsia. Other tests revealed serum lactate 2 mmol/L, CPK 512 U/L, and LDH 1008 U/L. Antinuclear antibody and rheumatoid factor were negative with normal serum complement levels. Admission chest radiography and a computerized tomography of the head were normal. A peripheral smear showed thrombocytopenia with low-grade microangiopathic hemolytic anemia (MAHA).

He was started on intravenous (IV) empiric antibiotics including vancomycin, cefepime, and metronidazole for a clinical suspicion of sepsis and also received platelet transfusion and IV heparin for DIC. Multiple blood cultures done during the hospitalization did not grow any organisms. Two days into admission, CSF cultures grew Streptococcus pneumonia, and antibiotics were switched to IV ceftriaxone (2 grams every 12 hours). His skin lesions progressed rapidly to hemorrhagic bullae. Skin biopsy showed widespread hemorrhage with focal thrombosis. The clinical picture of rapidly progressive ecchymotic skin rash in our patient with DIC secondary to Streptococcus pneumoniae infection was consistent with a diagnosis of PF, and the skin biopsy confirmed the same.

The patient’s hospital course was complicated by a transient worsening of his mental status, distal extremities thrombosis, and worsening renal function that required hemodialysis. With support care and antibiotic therapy (for a total of two weeks), he improved clinically. Upon discharge patient returned to his baseline mental status, his skin lesions cleared except the lesions on his lower extremities, and he remained on hemodialysis.

3. Discussion

Purpura fulminans is a rare, severe skin disorder associated with DIC that primarily affects children and infants. Extensive areas of skin develop blueblack hemorrhagic necrosis; biopsy reveals small-vessel microthrombi and occasionally mild vasculitis. In our patient the clinical findings are suggestive of microangiopathic thrombosis with hemolysis secondary to DIC and purpura fulminans. The pathogenesis is unknown, but histologic findings have been likened to the animal model of consumptive coagulopathy [1]. It has also been suggested that the development of acquired defects in the protein C pathway similar to two other protein C deficiency states, namely, neonatal purpura fulminans and warfarin-induced skin necrosis [2, 3]. In our patient, protein C was 87% (normal), and protein S was 15% (low).

The mortality rate has recently been significantly reduced in purpura fulminans, largely because of more widespread use of therapeutic heparinization in these patients and aggressive replacement of platelets and coagulation factors [4, 5]. Our patient also improved clinically with these interventions.

The most common organisms producing DIC are bacterial, especially the gram-negative bacteria (meningococci, Haemophilus influenzae, Aerobacter, and others) but also gram-positive organisms (Staphylococcus aureus, group B streptococci, Streptococcus pneumonia, and Bacillus anthracis). DIC is also associated with disseminated viral (varicella, measles, and rubella), rickettsial (Rocky Mountain spotted fever), fungal, mycoplasma, and parasitic infections. In our patient, Streptococcus pneumoniae was eventually grown from the CSF.

Clinically, patients with PF present with painful, erythematous macular lesions, and ecchymoses. These lesions evolve into painful indurated, well-demarcated purple papules with erythematous borders. Finally, they progress to necrosis with the formation of bullae and vesicles. In our patient, these skin lesions helped in the early diagnosis and eventual successful treatment of PF.

Streptococcus pneumoniae is the most common cause of meningitis in adults, particularly in elderly [6, 7]. It is common to have completely normal CSF cellularity and biochemistry in patients with bacterial meningitis [8, 9]. Despite these typical CSF findings, the spectrum of CSF values in bacterial meningitis is so wide that the absence of one or more of the typical findings is of little value [8, 9]. Similar to our patient where no abnormalities were found in the initial CSF analysis, in a series of 696 episodes of community-acquired bacterial meningitis, 12 percent had none of the characteristic CSF findings [9]. The explanation for minimal CSF abnormalities cannot usually be identified. Potential causes include early presentation, recent prior antibiotic therapy, and neutropenia. The normal CSF seen initially in our patient may be due to his early presentation to the ED.

Bacterial meningitis should be kept in the differential diagnoses in patients with otherwise unexplained DIC, especially with progressive altered mental status despite initial normal CSF analysis. Early clinical recognition of PF is essential for the successful outcome.

Conflict of Interests

The authors declare that they have no conflict of interests.

References

  1. T. E. Spicer and J. M. Rau, “Purpura fulminans,” American Journal of Medicine, vol. 61, no. 4, pp. 566–571, 1976. View at: Google Scholar
  2. R. M. Antley and C. W. McMillan, “Sequential coagulation studies in purpura fulminans,” The New England Journal of Medicine, vol. 276, no. 23, pp. 1287–1290, 1967. View at: Google Scholar
  3. R. B. Francis, “Acquired purpura fulminans,” Seminars in Thrombosis and Hemostasis, vol. 16, no. 4, pp. 310–325, 1990. View at: Google Scholar
  4. R. W. Evans, B. Glick, F. Kimball, and M. Lobell, “Fatal intravascular consumption coagulopathy in meningococcal sepsis,” The American Journal of Medicine, vol. 46, no. 6, pp. 910–918, 1969. View at: Google Scholar
  5. W. H. Hall, “Purpura fulminans with group B β-hemolytic streptococcal endocarditis,” Archives of Internal Medicine, vol. 116, no. 4, pp. 594–597, 1965. View at: Google Scholar
  6. M. L. Durand, S. B. Calderwood, D. J. Weber et al., “Acute bacterial meningitis in adults—a review of 493 episodes,” The New England Journal of Medicine, vol. 328, no. 1, pp. 21–28, 1993. View at: Publisher Site | Google Scholar
  7. S. I. Aronin, P. Peduzzi, and V. J. Quagliarello, “Community-acquired bacterial meningitis: risk stratification for adverse clinical outcome and effect of antibiotic timing,” Annals of Internal Medicine, vol. 129, no. 11, pp. 862–869, 1998. View at: Google Scholar
  8. M. T. Fitch and D. van de Beek, “Emergency diagnosis and treatment of adult meningitis,” The Lancet Infectious Diseases, vol. 7, no. 3, pp. 191–200, 2007. View at: Publisher Site | Google Scholar
  9. D. Van De Beek, J. De Gans, L. Spanjaard, M. Weisfelt, J. B. Reitsma, and M. Vermeulen, “Clinical features and prognostic factors in adults with bacterial meningitis,” The New England Journal of Medicine, vol. 351, no. 18, pp. 1849–1923, 2004. View at: Publisher Site | Google Scholar

Copyright © 2012 Erick F. Alvarez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

5429 Views | 833 Downloads | 1 Citation
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

Related articles

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19. Sign up here as a reviewer to help fast-track new submissions.